Boehringer Ingelheim
Ridgefield, USA
Ridgefield, USA
Dr. Jeff Song received his undergraduate education at Nankai University in Tianjin, China (1989 to 1992). After a brief stay at Rice University in Houston, TX, he moved to the Massachusetts Institute of Technology in 1993 and obtained his Ph.D. degree in 1998. Subsequently, he joined the Department of Chemical Development at Boehringer Ingelheim Pharmaceuticals in Ridgefield, CT, as a Senior Scientist. In the ensuing years, Dr. Song achieved a series of promotions from Senior Scientist to Senior Principal Scientist on the scientific ladder, followed by promotions to Director of Process Research on the managerial track. In 2018, Dr. Song was appointed Vice President and Department Head of Chemical Development in the U.S., overseeing all functions, including Process Research, Flow Chemistry, Chemical and Bio Catalysis, Digitalization Development, Analytical Research, Radiosynthesis, Kilolab, Pilot Plant, and External Chemistry Management. In 2025, Dr. Song assumed additional responsibility as the Site Head for the Development CMC US organization in Ridgefield. Dr. Song has over 27 years of experience in leading innovation, people, and teams, as well as a proven record of implementing cutting-edge technologies on an industrial scale to achieve higher efficiencies and cost savings in API synthesis. Dr. Song has authored and co-authored over 130 research papers, review articles, patent applications, and book chapters, including some “Most-Cited” and “Most-Accessed” papers. Over the years, Dr. Song has delivered many invited lectures at international conferences as well as academic institutions. Some of his work has also received media attention and has been highlighted in Chemical & Engineering News as well as a number of other professional magazine interviews.